These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Studies on clearing factor lipase (CFL) of postheparin plasma. MONKHOUSE FC; STRACHAN J; MCCLAIN F Can J Biochem Physiol; 1961 Jun; 39():1027-36. PubMed ID: 13772039 [No Abstract] [Full Text] [Related]
5. The effects of post-heparin plasma lipases on anti-Xa clotting activity. Williams SP; Barrowcliffe TW Thromb Res; 1985 Feb; 37(3):371-7. PubMed ID: 3992526 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein lipase and hepatic triacylglycerol lipase activities in peripheral and skeletal muscle lymph. Huang J; Sloop CH; Roheim PS; Wong L Arteriosclerosis; 1990; 10(5):720-6. PubMed ID: 2403299 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin). Persson E Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005 [TBL] [Abstract][Full Text] [Related]
8. The effect of heparin on the early stages of blood coagulation. O'BRIEN JR J Clin Pathol; 1960 Mar; 13(2):93-8. PubMed ID: 14428016 [TBL] [Abstract][Full Text] [Related]
10. [Heparin and lipoprotein lipase]. MOSSO HE; PERGOLA F Dia Med; 1962 Mar; 34():220-2. PubMed ID: 14476563 [No Abstract] [Full Text] [Related]
11. [Research on lipoprotein lipase. III. Post-heparin lipoprotein lipase in man under normal and pathological conditions]. SANDHOFER F; SAILER S; BRAUNSTEINER H Klin Wochenschr; 1961 Sep; 39():968-71. PubMed ID: 14496851 [No Abstract] [Full Text] [Related]
12. Reduced dimerization of lipoprotein lipase in post-heparin plasma of a patient with hyperchylomicronemia. Masuno H; Nakabayashi H; Kobayashi J; Saito Y; Okuda H Biochim Biophys Acta; 1995 Jan; 1254(1):30-6. PubMed ID: 7811743 [TBL] [Abstract][Full Text] [Related]
13. Changes in blood coagulation during the clearing of lipid emulsions by lipoprotein lipase. HIRSCH RL; KELLNER A; IRELAND R J Exp Med; 1960 Oct; 112(4):699-712. PubMed ID: 13714590 [TBL] [Abstract][Full Text] [Related]
14. Heparin-released lipolytic and esterolytic activities of human and rabbit plasmas. SHORE B; SHORE V Am J Physiol; 1961 Nov; 201():915-22. PubMed ID: 13912249 [No Abstract] [Full Text] [Related]
15. The effect of heparin on diamine oxidase and lipoprotein lipase in human lymph and blood plasma. Dahlbäck O; Hansson R; Tibbling G; Tryding N Scand J Clin Lab Invest; 1968; 21(1):17-25. PubMed ID: 4966101 [No Abstract] [Full Text] [Related]
16. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism. Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670 [TBL] [Abstract][Full Text] [Related]
17. [LIPOPROTEIN LIPASE AS A HUMORAL AGENT OF THE PHYSIOLOGICAL ANTICOAGULATING SYSTEM]. KUDRIASHOV BA; BAZAZIAN GG; TRAPEZNIKOVA SS; NOSOVA VN Biull Eksp Biol Med; 1963 May; 55():20-5. PubMed ID: 14077737 [No Abstract] [Full Text] [Related]
18. Pharmacokinetics of heparin and its pharmacodynamic effect on plasma lipoprotein lipase activity and coagulation in healthy horses. McCann ME; Watson TD; Boudinot FD; Moore JN Am J Vet Res; 1995 Aug; 56(8):1070-4. PubMed ID: 8533979 [TBL] [Abstract][Full Text] [Related]
19. New aspects on heparin and lipoprotein metabolism. Olivecrona T; Bengtsson-Olivecrona G; Ostergaard P; Liu G; Chevreuil O; Hultin M Haemostasis; 1993 Mar; 23 Suppl 1():150-60. PubMed ID: 8388350 [TBL] [Abstract][Full Text] [Related]
20. [Coagulation time in subcutaneous heparin treatment]. von AHN Sven Lakartidn; 1959 Dec; 56():3409-16. PubMed ID: 13792141 [No Abstract] [Full Text] [Related] [Next] [New Search]